FDA approval is expected to trigger Medicare reimbursement step-up, while UnitedHealth Group covers the test ahead of guidelines.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approval is expected to trigger Medicare reimbursement step-up, while UnitedHealth Group covers the test ahead of guidelines.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Milestone Scientific is utilizing First Coast for reimbursement coverage and has successfully received Medicare reimbursement for its CompuFlo product.Sub-event
FDA approval expected to trigger Medicare reimbursement step-up, with UHG covering the test early.1 source
Keep exploring
The entities involved
- FDA
-
Medicare
US federal health insurance
-
UnitedHealth Group
for-profit health care company
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- Daniel Solomon urges reform of Medicare reimbursement policy while a new U.S. Customs and Border Protection rule threatens affordable drug imports from Canada.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- FDA provided guidance for HCW Biologics' IND application.
- Medical societies and AAP challenge FDA guidance on e-cigarettes, while Congress grants FDA authority to regulate tobacco.